Categories AlphaGraphs, Earnings, Health Care
VRTX Earnings: A snapshot of Vertex Pharmaceuticals’ Q1 2023 results
Healthcare firm Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) on Monday reported a decline in adjusted earnings for the first quarter, despite an increase in revenues.
Total revenues increased to $2.37 billion in the first quarter from $2.10 billion in the corresponding period of 2022. For the full fiscal year, the management expects product revenues to be between $9.55 billion and $9.70 billion.
Meanwhile, adjusted earnings dropped to $3.05 per share in the March quarter from $3.52 per share in the prior-year period. Unadjusted profit was $699.8 million or $2.69 per share, compared to $762.1 million or $2.96 per share last year.
Prior Performance
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Most Popular
KMI Earnings: Kinder Morgan reports financial results for Q3 2024
Energy infrastructure company Kinder Morgan, Inc. (NYSE: KMI) on Wednesday reported financial results for the third quarter of 2024. Net income, adjusted for special items, remained unchanged year-over-year at $0.25
Earnings Preview: General Motors’ Q3 results likely to benefit from EV growth
General Motors Co. (NYSE: GM) is expected to report its third-quarter results on October 22. The company is working towards the goal of achieving operating profit in its rapidly growing
What to expect when Philip Morris (PM) reports Q3 2024 earnings results
Shares of Philip Morris International Inc. (NYSE: PM) stayed green on Wednesday. The stock has gained 11% over the past three months. The tobacco giant is scheduled to report its
